Retour
Fourchette du Jour
116,26 €
119,85 €
Fourchette 52 Semaines
92,52 €
212,00 €
Volume
434 661
Moyenne 50J / 200J
144,78 €
/
160,76 €
Clôture Précédente
118,14 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -86,1 | 0,4 |
| P/B | 25,1 | 2,9 |
| ROE % | -36,6 | 3,9 |
| Net Margin % | -6,0 | 3,8 |
| Rev Growth 5Y % | 23,3 | 10,0 |
| D/E | 4,8 | 0,2 |
Objectif de Cours des Analystes
Hold
210,91 €
+77.7%
Low: 184,00 €
High: 244,00 €
BPA Prévisionnel
-0,32 €
CA Est.
880 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
2,40 €
2,37 € – 2,45 €
|
1,4 B | 1 |
| FY2028 |
1,86 €
1,57 € – 2,38 €
|
1,2 B | 3 |
| FY2027 |
0,83 €
0,37 € – 1,28 €
|
1 B | 8 |
Points Clés
Revenue grew 23,34% annually over 5 years — strong growth
Debt/Equity of 4,79 — high leverage
Generating 34,52M in free cash flow
Capital efficient — spends only 6,20% of revenue on capex
Croissance
Revenue Growth (5Y)
23,34%
Revenue (1Y)26,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-36,57%
ROIC-3,12%
Net Margin-5,96%
Op. Margin-4,93%
Sécurité
Debt / Equity
4,79
Current Ratio4,63
Interest Coverage-2,80
Valorisation
P/E Ratio
-86,10
P/B Ratio25,11
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26,24% | Revenue Growth (3Y) | 23,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23,34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 747,14M | Net Income (TTM) | -44,55M |
| ROE | -36,57% | ROA | -4,37% |
| Gross Margin | 70,57% | Operating Margin | -4,93% |
| Net Margin | -5,96% | Free Cash Flow (TTM) | 34,52M |
| ROIC | -3,12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4,79 | Current Ratio | 4,63 |
| Interest Coverage | -2,80 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -86,10 | P/B Ratio | 25,11 |
| P/S Ratio | 5,13 | PEG Ratio | 2,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,84B | Enterprise Value | 4,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 747,14M | 591,84M | 492,68M | 410,92M | 322,83M |
| Net Income | -44,55M | -113,29M | -123,41M | -116,16M | -101,36M |
| EPS (Diluted) | -1,39 | -3,63 | -4,04 | -3,88 | -3,46 |
| Gross Profit | 527,25M | 407,53M | 331,81M | 281,63M | 213,57M |
| Operating Income | -36,81M | -115,51M | -125,16M | -113,78M | -99,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,02B | 931,45M | 433,14M | 448,22M | 462,97M |
| Total Liabilities | 867,30M | 840,54M | 223,05M | 208,41M | 183,45M |
| Shareholders' Equity | 152,75M | 90,91M | 210,10M | 239,81M | 279,52M |
| Total Debt | 731,18M | 736,91M | 129,82M | 131,04M | 117,71M |
| Cash & Equivalents | 236,01M | 419,60M | 36,17M | 78,83M | 127,56M |
| Current Assets | 702,77M | 645,82M | 230,81M | 288,77M | 305,52M |
| Current Liabilities | 151,89M | 110,92M | 107,37M | 89,10M | 87,85M |